Global collaboration across life science data infrastructures boosted by Australian BioCommons, Bioplatforms Australia and EMBL
A new Memorandum of Understanding (MoU) between Australian BioCommons, Bioplatforms Australia, and the European Molecular Biology Laboratory (EMBL) recognises the scientific benefits of collaboration between researchers from different countries, and the importance of Australian and European cooperation in science and technology.
Key areas of collaboration described in the MoU that will take place over the next 5 years include:
scientific collaboration (with a particular focus on AI, Data, Services, Infrastructure, and Omics);
access to shared services and infrastructure;
development and delivery of training opportunities (especially for early-career researchers), scientific visits, joint meetings, conferences, and workshops; and
possible collaboration on joint funding opportunities.
The collaboration will build on an existing multi-decade history of engagement between the parties across several established strengths including the delivery of training programs, staff exchanges, international knowledge sharing, and joint collaborative activities to establish and advance life sciences bioinformatics infrastructure. The parties have complementary natures, scientific strengths, and missions, particularly in bioinformatics and data provision. All three are committed to the mutual benefits of international partnerships to foster scientific knowledge, skills, and innovation.
Bioplatforms Australia supports life science research by investing in infrastructure and expertise in genomics, proteomics, metabolomics, and bioinformatics. Australian BioCommons, supported by Bioplatforms Australia, provides national bioinformatics infrastructure. EMBL is a leading intergovernmental organisation in molecular biology, with its European Bioinformatics Institute (EMBL-EBI) serving as a world-leading source of public biological data.
Read Bioplatforms Australia’s announcement here
Read EMBL’s announcement here